launched Discover in 1985 as part of a financial-services strategy, but in 1993 spun it off as Dean Witter, Discover & Co
Small molecule drugs Currently, there are 2 small molecule drugs targeting GCGR in clinical development: PegBios GCGR -only agonist PB-722 and the Tianjin Instituteof Pharmaceutical Researchs GCGR x GLP-1R dual agonist TY-751.Bothof these drugs have had their clinical trial applications accepted for review
It is commonly used in laboratory research to investigate: Peptide signaling pathways in tissue and muscle models Cellular mechanisms in connective tissue studies Collagen and extracellular matrix research In vitro and ex vivo models of tissue response Experimental designs involving tendon, ligament, and joint tissues The 5mg dosage provides sufficient material for single-dose, multi-dose, or extended laboratory experiments
Pregnant or breastfeeding individuals, and anyone with a history of seizures or active cancer, should consult a provider before considering it
Stress management matters more than many realize
